Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FTC complaint filed over Enviga

This article was originally published in The Tan Sheet

Executive Summary

The Center for Science in the Public Interest files a complaint with the Federal Trade Commission over weight-loss claims for Enviga May 21. "Enviga drinkers are being suckered into paying a premium for calorie-burning benefits they are not receiving," the complaint says. Coca-Cola/Nestle published a study to substantiate its product in February (1"The Tan Sheet" Feb. 19, 2007, In Brief). However, the study consisted of 31 lean subjects and lasted 72 hours. CSPI also filed suit against the companies in February in the U.S. District Court for the District of New Jersey (2"The Tan Sheet" Feb. 5, 2007, In Brief). The consumer group urges FTC to enjoin the companies from making further weight-loss claims regarding Enviga as well as to require a monetary penalty and corrective advertising. Coca-Cola and Nestle launched Enviga nationwide in January (3"The Tan Sheet" Oct. 23, 2006, p. 11)...

Related Content

Topics

UsernamePublicRestriction

Register

PS100545

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel